First-line temozolomide (TEM) combined with bevacizumab (BEV) in metastatic melanoma (MM): A multicenter phase II trial (SAKK 50/07)

被引：5

作者：

Dummer, R.

Michielin, O.

Seifert, B.

Ochsenbein, A. F.

Cathomas, R.

Schlaeppi, M. R.

Simcock, M.

Gillessen, S.

Goldinger, S. M.

von Moos, R.

机构：

[1] Univ Zurich Hosp, CH-8091 Zurich, Switzerland

[2] CHU Vaudois, Lausanne, Switzerland

[3] Univ Basel, Basel, Switzerland

[4] Inselspital Bern, CH-3010 Bern, Switzerland

[5] Kantonsspital Graubunden, Chur, Switzerland

[6] Kantonsspital St Gallen, St Gallen, Switzerland

[7] SAKK Coordinating Ctr, Bern, Switzerland

[8] Kantonsspitat St Gallen, Dept Med Oncol, St Gallen, Switzerland

[9] Univ Zurich, Zurich, Switzerland

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.8521

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8521

引用

页数：1